By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warnex Pro-DNA Services today announced a contribution agreement with Canada's federal research and development organization to develop a pre-screening method for forensic mitochondrial DNA testing.

Under the deal, the National Research Council of Canada Industrial Research Assistance Program will provide Warnex Pro-DNA up to C$49,200 (US$48,000) in funding, as well as technical and business advisory services.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.